130 related articles for article (PubMed ID: 38518995)
21. Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.
Snowdon VK; Lachlan NJ; Hoy AM; Hadoke PW; Semple SI; Patel D; Mungall W; Kendall TJ; Thomson A; Lennen RJ; Jansen MA; Moran CM; Pellicoro A; Ramachandran P; Shaw I; Aucott RL; Severin T; Saini R; Pak J; Yates D; Dongre N; Duffield JS; Webb DJ; Iredale JP; Hayes PC; Fallowfield JA
PLoS Med; 2017 Feb; 14(2):e1002248. PubMed ID: 28245243
[TBL] [Abstract][Full Text] [Related]
22. Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat.
Ceperuelo-Mallafré V; Näf S; Escoté X; Caubet E; Gomez JM; Miranda M; Chacon MR; Gonzalez-Clemente JM; Gallart L; Gutierrez C; Vendrell J
J Clin Endocrinol Metab; 2009 Dec; 94(12):5062-9. PubMed ID: 19846741
[TBL] [Abstract][Full Text] [Related]
23. In vitro effect of relaxin in the rat corpus cavernosum under hyperglycemic and normoglycemic conditions.
Acar-Sahan S; Guner O; Ates M; Kaya-Temiz T; Durmus N
Int J Impot Res; 2024 Feb; 36(1):72-77. PubMed ID: 36509910
[TBL] [Abstract][Full Text] [Related]
24. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway.
Wu XP; Wang HJ; Wang YL; Shen HR; Tan YZ
Exp Cell Res; 2018 Jan; 362(1):17-27. PubMed ID: 28987540
[TBL] [Abstract][Full Text] [Related]
25. Differential Expression of FXR and Genes Involved in Inflammation and lipid Metabolism Indicate Adipose Tissue Dysfunction in Gestational Diabetes.
Valencia-Ortega J; González-Reynoso R; Salcedo-Vargas M; Díaz-Velázquez MF; Ramos-Martínez E; Ferreira-Hermosillo A; Mercado M; Saucedo R
Arch Med Res; 2023 Apr; 54(3):189-196. PubMed ID: 36805269
[TBL] [Abstract][Full Text] [Related]
26. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.
Samaras K; Botelho NK; Chisholm DJ; Lord RV
Obesity (Silver Spring); 2010 May; 18(5):884-9. PubMed ID: 20019678
[TBL] [Abstract][Full Text] [Related]
27. Acute intravenous injection of serelaxin (recombinant human relaxin-2) causes rapid and sustained bradykinin-mediated vasorelaxation.
Leo CH; Jelinic M; Parkington HC; Tare M; Parry LJ
J Am Heart Assoc; 2014 Feb; 3(1):e000493. PubMed ID: 24584737
[TBL] [Abstract][Full Text] [Related]
28. Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.
Wolf VL; Phillips TL; Taylor EB; Sasser JM; Ryan MJ
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H234-H242. PubMed ID: 31125285
[TBL] [Abstract][Full Text] [Related]
29. Porcine Relaxin but Not Serelaxin Shows Residual Bioactivity after In Vitro Simulated Intestinal Digestion-Clues for the Development of New Relaxin Peptide Agonists Suitable for Oral Delivery.
Pacini L; D'Ercole A; Papini AM; Bani D; Nistri S; Rovero P
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613489
[TBL] [Abstract][Full Text] [Related]
30. Effects of serelaxin on renal microcirculation in rats under control and high-angiotensin environments.
Shao W; Rosales CB; Gonzalez C; Prieto MC; Navar LG
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F70-F80. PubMed ID: 28978531
[TBL] [Abstract][Full Text] [Related]
31. Serelaxin, recombinant human relaxin-2, for heart failure patients: A systematic review and meta-analysis.
Yu L; Cao L; Sun J; Li Z; Yao F; Zhou Y
Medicine (Baltimore); 2018 Jun; 97(25):e11010. PubMed ID: 29923986
[TBL] [Abstract][Full Text] [Related]
32. Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study.
Liesenfeld DB; Grapov D; Fahrmann JF; Salou M; Scherer D; Toth R; Habermann N; Böhm J; Schrotz-King P; Gigic B; Schneider M; Ulrich A; Herpel E; Schirmacher P; Fiehn O; Lampe JW; Ulrich CM
Am J Clin Nutr; 2015 Aug; 102(2):433-43. PubMed ID: 26156741
[TBL] [Abstract][Full Text] [Related]
33. Dietary fat content and adipose triglyceride lipase and hormone-sensitive lipase gene expressions in adults' subcutaneous and visceral fat tissues.
Zareie R; Yuzbashian E; Rahimi H; Asghari G; Zarkesh M; Hedayati M; Djazayery A; Movahedi A; Mirmiran P; Khalaj A
Prostaglandins Leukot Essent Fatty Acids; 2021 Feb; 165():102244. PubMed ID: 33445064
[TBL] [Abstract][Full Text] [Related]
34. Altered Cerebral Blood Flow and Potential Neuroprotective Effect of Human Relaxin-2 (Serelaxin) During Hypoxia or Severe Hypovolemia in a Sheep Model.
Schiffner R; Bischoff SJ; Lehmann T; Irintchev A; Nistor M; Lemke C; Schmidt M
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120997
[TBL] [Abstract][Full Text] [Related]
35. Impact of physical exercise on visceral adipose tissue fatty acid profile and inflammation in response to a high-fat diet regimen.
Rocha-Rodrigues S; Rodríguez A; Gonçalves IO; Moreira A; Maciel E; Santos S; Domingues MR; Frühbeck G; Ascensão A; Magalhães J
Int J Biochem Cell Biol; 2017 Jun; 87():114-124. PubMed ID: 28438715
[TBL] [Abstract][Full Text] [Related]
36. Impact of human visceral and glutealfemoral adipose tissue transplant on glycemic control in a mouse model of diet-induced obesity.
Tsiloulis T; Raajendiran A; Keenan SN; Ooi G; Taylor RA; Burton P; Watt MJ
Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E519-E528. PubMed ID: 32603261
[TBL] [Abstract][Full Text] [Related]
37. Adipose triglyceride lipase regulates lipid metabolism in dairy goat mammary epithelial cells.
Li J; Luo J; Wang H; Shi H; Zhu J; Sun Y; Yu K; Yao D
Gene; 2015 Jan; 554(1):125-30. PubMed ID: 25307872
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right target.
Bani D
Drug Discov Today; 2020 Jul; 25(7):1239-1244. PubMed ID: 32360533
[TBL] [Abstract][Full Text] [Related]
39. Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity.
Mairal A; Langin D; Arner P; Hoffstedt J
Diabetologia; 2006 Jul; 49(7):1629-36. PubMed ID: 16752181
[TBL] [Abstract][Full Text] [Related]
40. Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure.
Beldhuis IE; Ter Maaten JM; Figarska SM; Damman K; Pang PS; Greenberg B; Davison BA; Cotter G; Severin T; Gimpelewicz C; Felker GM; Filippatos G; Teerlink JR; Metra M; Voors AA
Clin Res Cardiol; 2023 Jul; 112(7):901-910. PubMed ID: 36656377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
